AI-Designed ADHD Peptide Goes from Concept to Wet Lab in 24 Hours for Under $1,500

Bio Protocol's PeptAI system designed a novel ADHD-targeting peptide and moved it to wet lab validation in a single day — a process that traditionally costs pharmaceutical companies millions.

Bio Protocol reported that its PeptAI system designed an ADHD-targeting peptide in 24 hours, with wet lab validation costs under $1,500. The company contrasted this with traditional pharmaceutical discovery timelines, where similar work takes months and costs millions.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. Vestibulum ante ipsum primis in faucibus orci luctus et ultrices posuere cubilia curae.

Unlock the full briefing

Get every story in today's briefing, the full archive, and the daily AI intelligence brief.

All stories today

Full archive

Daily brief